Bioxytran CEO David Platt, Ph.D. to Present at Noble Capital Markets' Emerging Growth Virtual Equity Conference

Rhea-AI Summary

Bioxytran (OTCQB:BIXT) announced that CEO David Platt, Ph.D. will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 5, 2026. The presentation includes a fireside Q&A and will overview corporate strategy, pipeline focus, and previously disclosed clinical and regulatory progress.

A video webcast will be available after the event and archived on the company website and Channelchek.com for 90 days.

News Market Reaction

+3.48%

1 alert

+3.48% News Effect

On the day this news was published, BIXT gained 3.48%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, MA / ACCESS Newswire / February 4, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company focused on the development of novel carbohydrate-based therapeutics, today announced that David Platt, Ph.D., Chief Executive Officer of Bioxytran, will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on Thursday, February 5, 2026.

Dr. Platt's formal presentation will feature a fireside-style Q&A session, with questions welcomed from the live virtual audience. The presentation is expected to provide an overview of Bioxytran's corporate strategy, pipeline focus, and previously disclosed clinical and regulatory progress.

A video webcast of the presentation will be available following the event on the Company's website and as part of the complete catalog of presentations available on Channelchek, the investor portal created by Noble Capital Markets. The webcast will be archived on both the Company's website and Channelchek.com for 90 days following the event.

About Bioxytran, Inc.

Bioxytran, Inc. (OTCQB:BIXT) is a clinical-stage biotechnology company developing platform technologies in glycovirology, hypoxia, and degenerative diseases. The Company's pipeline includes ProLectin-M, an investigational broad-spectrum antiviral candidate, as well as oxygen-transport and galectin-focused programs targeting conditions with significant unmet medical needs. Bioxytran leverages carbohydrate drug design and novel delivery approaches to address complex disease mechanisms.

For more information, please visit www.bioxytraninc.com.

About Noble Capital Markets

Established in 1984, Noble Capital Markets is an SEC / FINRA registered full-service investment bank and advisory firm with an award-winning research team and proprietary investor distribution platform. Noble delivers middle-market expertise to entrepreneurs, corporations, financial sponsors, and investors. Over the past 40 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports.

About Channelchek

Noble launched Chanelchek in 2018-an investor community dedicated exclusively to public emerging growth companies and their industries. Channelchek is the first service to offer institutional-quality research to the public for free, without a subscription. More than 7,000 public emerging growth companies are listed on the site, with content including equity research, webcasts, and industry articles.

Please do not hesitate to reach out with any additional questions.

Noble Conference Team
Noble Capital Markets, Inc.
150 East Palmetto Park Rd, Suite 110
Boca Raton, FL 33432
www.noblecapitalmarkets.com

SOURCE: Bioxytran, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Bioxytran (BIXT) present at the Noble Capital Markets virtual conference?

Bioxytran will present on Thursday, February 5, 2026, at Noble Capital Markets' virtual Emerging Growth conference. According to Bioxytran, CEO David Platt will deliver a formal presentation including a fireside-style Q&A for live attendees.

How can investors watch the Bioxytran (BIXT) presentation on February 5, 2026?

Investors can join the live virtual presentation via Noble Capital Markets' conference platform on the event date. According to Bioxytran, a video webcast will also be posted afterwards on the company's website and on Channelchek.com.

Will the Bioxytran (BIXT) webcast be available after the Noble Capital Markets event?

Yes. The webcast will be archived and available for replay for 90 days after the event. According to Bioxytran, the recording will be hosted on the company website and Channelchek.com for the stated period.

What topics will CEO David Platt cover in the Bioxytran (BIXT) presentation?

The presentation will cover corporate strategy, pipeline focus, and previously disclosed clinical and regulatory progress. According to Bioxytran, the session includes a fireside Q&A to address live audience questions.

Can attendees ask questions during the Bioxytran (BIXT) Noble Capital Markets session?

Yes. Audience questions are welcomed during the fireside-style Q&A portion of the presentation. According to Bioxytran, the format explicitly invites questions from the live virtual audience during the session.

Where will the archived Bioxytran (BIXT) presentation be hosted after the conference?

The archived presentation will be hosted on both the company's investor website and Channelchek.com for 90 days. According to Bioxytran, both platforms will carry the recorded webcast as part of their catalogs.